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HMGB4 is expressed by neuronal 
cells and affects the expression 
of genes involved in neural 
differentiation
Ari Rouhiainen1,2, Xiang Zhao1,3, Päivi Vanttola1, Kui Qian4, Evgeny Kulesskiy1,5, Juha Kuja-
Panula1, Kathleen Gransalke1, Mikaela Grönholm2, Emmanual Unni6, Marvin Meistrich7, 
Li Tian1,8, Petri Auvinen4 & Heikki Rauvala1
HMGB4 is a new member in the family of HMGB proteins that has been characterized in sperm cells, 
but little is known about its functions in somatic cells. Here we show that HMGB4 and the highly similar 
rat Transition Protein 4 (HMGB4L1) are expressed in neuronal cells. Both proteins had slow mobility 
in nucleus of living NIH-3T3 cells. They interacted with histones and their differential expression in 
transformed cells of the nervous system altered the post-translational modification statuses of histones 
in vitro. Overexpression of HMGB4 in HEK 293T cells made cells more susceptible to cell death induced 
by topoisomerase inhibitors in an oncology drug screening array and altered variant composition 
of histone H3. HMGB4 regulated over 800 genes in HEK 293T cells with a p-value ≤0.013 (n = 3) in a 
microarray analysis and displayed strongest association with adhesion and histone H2A –processes. In 
neuronal and transformed cells HMGB4 regulated the expression of an oligodendrocyte marker gene 
PPP1R14a and other neuronal differentiation marker genes. In conclusion, our data suggests that 
HMGB4 is a factor that regulates chromatin and expression of neuronal differentiation markers.
HMGB-proteins are less than 30 kDa in size and bind to DNA in a manner that is dependent on the structure of 
the DNA and mainly independent of the sequence of the DNA1. HMGB1, -2 and -3 proteins are widely expressed 
in eukaryotes and highly conserved between species. They are composed of two DNA-binding HMGB-boxes and 
an acidic tail. HMGB4 is a mammalian specific protein that has two HMGB-boxes but lacks the acidic tail. Its 
nucleotide sequence is less conserved than the sequences of the other HMGB genes2.
Unlike other HMGB-proteins, HMGB4 has a very restricted expression pattern with extremely low expres-
sion levels in somatic cells. HMGB4 mRNA is undetectable during mouse embryonal development at the E10.5 
stage but it is expressed in the brain and the pancreas at E12.5 and E14 stages, respectively3–5. During adulthood, 
the highest HMGB4 expression levels are observed in testes in round spermatids, elongating spermatids and in 
spermatocytes6. At the chromosomal level it localizes to transcriptionally inactive sex bodies of pachytene sper-
matocytes6. Lower expression levels of HMGB4 during adulthood are seen in the kidney and in the brain2. In rats 
the closely related protein Transition Protein 4 (TP4) is believed to be exclusively found in nuclei of elongating 
spermatids7. The regulation mechanism of the HMGB4 gene is still mainly uncharacterized. In spermatozoa an 
active histone methylation mark, histone H3 dimethylated lysine 4, is present in the HMGB4 promoter indicating 
active transcription in haploid sperm cells8.
The functional role of endogenous HMGB4 in somatic cells is poorly understood. Previous studies showed 
that it is downregulated during neurosphere differentiation5. In canine osteosarcomas the expression of HMGB4 
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Figure 1. Characterization of HMGB4 and HMGB4L1. (a) Alignment of rat TP4/HMGB4L1 and HMGB4 
amino acid sequences. HMGB-boxes A and B are underlined. Red letters indicate identical amino acids. An 
alternative allele in position 34 of TP4/HMGB4L1 is either a tyrosine or a isoleucine. Amino acids marked 
in italics have been identified by amino terminal amino acid sequencing7. Domain structures and number of 
amino acids of rat HMGB1, HMGB4 and TP4/HMGB4L1 are shown in the schematic picture. (b) Western 
–blot of recombinant mouse HMGB4. Recombinant HMGB4 was detected with Ponceau S –staining and 
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correlates with favorable prognosis and alterations in the HMGB4 gene region are associated with reoccurrence 
and death in melanoma9,10. Ectopic expression of HMGB4 in transformed cells represses transcription, inhibits 
cancer cell growth via the retinoblastoma dependent pathway, and potentiates the anti-cancer effects of both 
γ -ray irradiation and cisplatin2,11,12. Polymorphism in the human HMGB4 gene region have been associated with 
psychiatric disorders like ADHD and schizophrenia13,14. Further, HMGB4 expression in the mouse hippocampus 
is regulated by antidepressants, and in humans HMGB4 polymorphisms correlate with different antidepressant 
responses15,16.
Since HMGB4 is expressed during embryonal development and regulates growth of transformed cells, we have 
studied HMGB4 expression and cellular functions regulated by HMGB4 using transformed cell and developing 
brain cell models.
Results
Database searches revealed that both human and mouse have a single copy of the HMGB4-gene2,17, whereas 
the rat has two HMGB4-like genes, one on chromosome 5 and another one on the X-chromosome [coding 
for proteins HMGB4 (NP_001102933) and predicted high mobility group protein B4 –like (XP_006227590), 
respectively, in the NCBI database]. The predicted protein coded by the gene on the rat X-chromosome was 
identified as TP47 (accession number AAB24466). The amino acid sequences of the rat HMGB4 and TP4 are 
66% identical and 82% similar (Fig. 1a refs 2 and 7). TP4 is renamed high mobility group box 4 protein –like 1 
(HMGB4L1) in this study. Comparison of HMGB4 and HMGB4L1 to the amino acid sequence of the archetype 
of the HMGB-proteins, HMGB1, revealed that rat HMGB4 is 42% identical and 67% similar, and HMGB4L1 is 
43% identical and 66% similar.
A mouse recombinant HMGB4 protein is recognized by both anti-HMGB4 and anti-HMGB4L1 antibodies 
(Fig. 1b) suggesting immunogenic similarity. Both HMGB4 and HMGB4L1 are highly expressed in adult rat 
testes and coded by transcripts of approximately 1 kb size (Fig. 1c,d). Their expression occurs in elongated sper-
matids (Fig. 1e, refs 2,7,18), in brain (Supplementary Figure S2) and in neuronal cells (Fig. 1f).
We studied the functions of HMGB4 and HMGB4L1 using different cultured cell models. Similarly to 
HMGB4, HMGB4L1 localizes to the nucleus of cultured C6 cells (Fig. 2a). The mobility of EGFP –tagged HMGB 
–proteins in NIH-3T3 –cell nuclei was studied by the Fluorescence Recovery After Photobleaching (FRAP) assay 
using method described previously for the same cell line, which ectopically expresses HMGB –fusion proteins19. 
Half of the nucleus was photobleached and fluorescence recovery time was monitored. HMGB4-EGFP and 
HMGB4L1-EGFP had a similar mobility within the nucleus [half-time (t1/2) 5.3 ± 2.8 s and 8.3 ± 1.6 s, respec-
tively]. Compared to HMGB4-EGFP and HMGB4L1-EGFP, the HMGB1-EGFP displayed a clearly higher 
mobility, with a t1/2 of 1.8 ± 0.5 s that is similar to t1/2 of HMGB1 as described by others19,20. A human HMGB4 
nonsynonymous polymorph rs10379 was detected with restriction enzyme analysis and the mobility of proteins 
coded by the prominent allele and by the polymorphic allele was analyzed by another FRAP assay (Fig. 2b,c). In 
this particular assay bleaching and monitoring of fluorescence recovery was focused to one bright nuclear area, 
smaller than half of the nucleus, to obtain increased resolution. There was no difference in mobility between the 
forms coded by the prominent allele or by the polymorphic allele. However, fluorescence suggested existence of 
an immobile HMGB4-EGFP fraction that had not recovered during the time period observed. These results show 
that the two closely related proteins, HMGB4 and HMGB4L1, bind tightly to nuclei of living cells in contrast to 
HMGB1, which binds much more weakly.
STRING database21 searches suggested that HMGB4 interacts with transcription regulatory factors, histone 
H2A and topoisomerase II (Supplementary Table S1). Therefore we next analyzed the role of nuclear proteins in 
HMGB4 functions. Binding of nuclear proteins, isolated from C6 glioblastoma cells, to HMGB1 and HMGB4 
-affinity columns was studied, using a previously described method for recombinant HMGB –protein affinity col-
umn liquid chromatography22. Core histones bound to both HMGB1- and HMGB4-columns, whereas the linker 
histone H1 only bound to the HMGB1-column (Fig. 3a–d). The fractions were then analyzed for histone mod-
ifying enzymatic histone deacetylase (HDAC) and sirtuin activities. HDAC-activity was significantly increased 
in HMGB1 and HMGB4 elution fractions whereas sirtuin activity was not (Fig. 3e). Since HMGB4 associated 
with histones and HDACs we tested whether the transient ectopic expression of HMGB4 or HMGB4L1 in C6 
with anti-HMGB4 and anti-HMGB4L1 antibodies. The antibodies did not detect recombinant HMGB1. 
(c) Northern Blot -analysis of the mouse HMGB4 transcript. Total RNA samples were isolated from adult 
mouse testes and analyzed via Northern Blot, using a probe derived from the entire coding sequence of mouse 
HMGB4. The probe detected a 1.1 kb band. Ethidum bromide stained ribosomal RNA is shown. (d) Northern 
Blot -analysis of rat HMGB4L1 transcript. Total RNA samples were isolated from adult rat testes and from 
developing rat testes, and analyzed via Northern Blot, using a probe derived from the entire coding sequence of 
rat HMGB4L1. The probe detected a 0.9 kb band in samples derived from testes of sexually mature rat. Ethidum 
bromide stained ribosomal RNA is shown. 3 w = 3 week old rat, 5 w = 5 week old rat. (e) Immunohistochemical 
staining of rat HMGB4L1 protein and in situ hybridization of mouse HMGB4 mRNA in adult testes. Anti-
HMGB4L1 polyclonal antibody staining revealed intense HMGB4L1 expression in elongated spermatids (red). 
Haematoxylin was used as a counterstain. Control sections were stained without the primary antibody. HMGB4 
mRNA localized to round and elongated spermatids. The control section shows adult mouse testes incubated 
with the sense probe. Bars represent 50 μ m. (f) Expression of HMGB4 and HMGB4L1 mRNA in cultured 
rat neurons. Neuronal cells from the hippocampus and the cerebellum were cultured, and both HMGB4 and 
HMGB4L1 expression (arrows) was detected with RT-PCR. + RT =  reverse transcribed, -RT =  without reverse 
transcription.
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Figure 2. Nuclear localization of HMGB4 and HMGB4L1. (a) Rat glioblastoma C6 –cells transiently 
transfected with V5-tagged HMGB4 and HMGB4L1 were double immunostained with anti-V5-tag and anti-
acetylated K9/K14 histone H3 antibodies. Immunofluorescence staining intensity of anti-acetylated K9/K14 
histone H3 is reduced in C6 –cells transiently expressing HMGB4 or HMGB4L1. Arrows indicate HMGB4- 
and HMGB4L1-positive nuclei in double immunostained cells. Scale bar 20 = μ m. (b) Single nucleotide 
polymorphism of the human HMGB4 gene. Genomic DNA of different human cell lines was amplified in PCR 
with primers specific to HMGB4 gene and subjected to Ban 1 restriction enzyme analysis. SNP rs10379 destroys 
Ban 1 cleavage site in the coding sequence of HMGB4 gene. Gel figure indicates that HT1080 and Jurkat cells 
are heterozygotes for rs10379 SNP. (c) Nuclear mobility FRAP analyses of wild type HMGB4 and rs10379 
polymorphic human HMGB4 protein forms. NIH-3T3 -cells were transfected with an expression vector coding 
for the prominent allele or the polymorphic allele of human HMGB4-EGFP fusion proteins. One brightly 
fluorescent area in the nucleus with high expression of HMGB4-EGFP was bleached with three laser pulses and 
recovery of fluorescence was measured. Values from pre-bleach areas were determined as 1 and normalized 
values for bleached areas were calculated. The failing of full fluorescent recovery indicates the existence of an 
immobile fraction of HMGB4-EGFP in the nucleus. Triangles = wild type HMGB4, squares = SNP form of 
HMGB4; n = 5; ± SD.
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Figure 3. Interactions of HMGB4 and HMGB4L1 with histones. (a,b) Binding of C6 -cell nuclear proteins 
to HMGB-protein affinity columns. Proteins in elution fractions were analyzed with silver stained SDS-PAGE. 
The bands, representing core histones, are indicted with marks on the left. a = HMGB1 –affinity column, 
b = HMGB4 –affinity column. (c) Core histones eluted from HMGB-protein affinity columns and histones 
were quantified with ELISA. Affinity chromatography was done as described above (n ≥ 3, *p < 0.05, ± SD; 
Ac = acetylated, 2Me = di-methylated, 3Me = tri-methylated (lysine)). (d) HMGB1 and HMGB4 differ in their 
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cells or downregulation of endogenous HMGB4 in NTERA2 cl. D1 cells affects the histone post-translational 
modification. The intensities of anti-acetylated histone H3 K9/K14 and anti-methylated histone H3 K27 stain-
ing in HMGB4/HMGB4L1 overexpressing cells were quantified. Acetylated histone H3 K9/K14 and HMGB4/
HMGB4L1 stainings were negatively correlated. In contrast, trimethylated histone H3 K27 and HMGB4/
HMGB4L1 stainings were positively correlated. There was no correlation between dimethylated histone H3 K27 
and HMGB4/HMGB4L1 stainings (Fig. 3f). To monitor the effect of HMGB4 loss on the regulation of protein lev-
els we stably transfected NTERA-2 cl. D1 cells with HMGB4 shRNA. HMGB4 shRNA-expressing cells expressed 
lower levels of HMGB4 and elevated levels of acetylated histones H2A and H4 (Fig. 3g). Taken together, these 
results show that both HMGB1 and HMGB4 are associated with core histones and HDACs, and that HMGB4 and 
HMGB4L1 regulate post-translational modifications of histones in transformed cells derived from the central 
nervous system.
To further characterize HMGB4 function in somatic cells, doxycycline induced HMGB4-EGFP –overexpress-
ing and constantly HMGB4-EGFP overexpressing HEK 293T -cells were generated through lentivirus infec-
tion. Both clones proliferated similarly when compared to EGFP –expressing controls (Fig. 4a,b). Constantly 
overexpressing HMGB4-EGFP and EGFP expressing cell clones were further analyzed in a drug sensitivity and 
resistance testing screen with 279 drugs from an oncology collection library23 (Institute for Molecular Medicine, 
Finland). The most promising hits included topoisomerase inhibitors that were selected for further validation. 
Inhibitors of topoisomerases induced the death of HMGB4 expressing cell cultures at lower concentrations than 
in control cell cultures (Fig. 4c). These results are consistent with STRING –search results that suggested HMGB4 
interactions with topoisomerase 2A and 2B (Supplementary Table S1). Since our STRING search also suggested 
that HMGB4 interacts with histones (Supplementary Table S1) and HMGB4 associates with core histones 
(Fig. 3b,c) we analyzed the expression of histones and histone variants in HMGB4-expressing cells. The relative 
amount of histone H3.2 was elevated in the HMGB4-EGFP -expressing cells when compared to the control cells 
(Fig. 4d,e). No changes in the composition of the other core histone or the linker histone H1 protein fractions 
were observed in the RP-HPLC analyses. These results indicate that HMGB4 can induce changes in the sensitivity 
to topoisomerase inhibitors and in histone composition.
Microarray analysis further indicated that the exogenous expression of HMGB4-EGFP is a strong mod-
ulator of transcription since the expression of more than 800 genes with p-values ≤ 0.013 (n = 3) was altered 
(Supplementary Table S2). The HMGB4-EGFP construct induced changes in gene expression related to cell 
adhesion, histones and nucleosomes, vasculature development, cirtullination and processes involving the tumor 
necrosis factor receptor (Table 1). For example, the expression of many histone variants was significantly changed, 
including histones H1c, H2ab, H2ad, H2ae and H3d in histone cluster 1, and histone H2ab in histone cluster 2 
and H2a in histone cluster 3. In addition, many pro- and anti-apoptotic genes were regulated. However, there was 
not any clearly increasing or decreasing trend in the expression of apoptosis associating genes in qPCR analysis of 
HMGB4-EGFP –expressing cells (Supplementary Figure S1).
The most significant change in gene expression, induced by HMGB4-EGFP in microarray analyses was seen 
in the expression level of the PPP1R14a gene, which was downregulated approximately 140 –fold (Supplementary 
Table S2). PPP1R14a codes for protein phosphatase 1 regulatory subunit 14A (also known as C-kinase activated 
Protein phosphatase-1 Inhibitor of 17 kDa, CPI-17) that regulates multiple cellular functions, including cell 
adhesion, tumorigenesis and brain development. PPP1R14a downregulation in HMGB4-EGFP expressing cell 
clones was further evaluated by qPCR (Fig. 5a). To confirm that HMGB4 directly regulates the expression of 
the PPP1R14a gene in transformed cells we knocked down endogenous HMGB4 translation in mouse C2C12 
myoblast cells (Fig. 5b). When these cells were treated with HMGB4 Vivo-Morpholinos, they expressed higher 
levels of PPP1R14a mRNA than the cells treated with standard control Vivo-Morpholinos. As our microarray 
data revealed, cell adhesion processes were most significantly affected in HMGB4 –overexpressing cells (Table 1). 
Knock down experiments suggested the possibility that one relevant HMGB4 regulated mechanism in cells is 
PPP1R14a-dependent regulation of phosphorylation of cell adhesion controlling proteins. One such protein is 
merlin, when phosphorylated, is a key regulator of adhesion in many cell types24–27. Therefore we tested mer-
lin phosphorylation in HMGB4 overexpressing cells. The relative phosphorylation state of merlin remained 
unaltered in cell cultures expressing HMGB4-EGFP when compared to control EGFP –expressing cell cultures 
(0.60 ± 0.31 and 1.00 ± 0.08, respectively). This suggests that other processes than merlin phosphorylation 
dependent cell adhesion are relevant in HMGB4 mediated regulation of PPP1R14a.
histone H1 binding capacity. Affinity chromatography was done as described above and eluted proteins were 
analyzed with histone H1 ELISA. Elution peak areas were quantified (n = 3, ± SD, *p < 0.002). (e) HDACs bind 
to HMGB1 and HMGB4. Nuclear proteins were analyzed with affinity chromatography as described above 
except that eluted fractions from each column were pooled to form a single fraction. Relative HDAC and sirtuin 
activities in elution fractions were determined (n ≥ 3 in each experiment, ± SD). (f ) Immunofluorescence 
intensities of modified histone antibody stained HMGB4 or HMGB4L1 overexpressing cells. Rat glioblastoma 
C6- cells transiently expressing HMGB4-V5 or HMGB4L1-V5 were double-immunostained with anti-
acetylated (K9/K14), anti-dimethylated K27 or anti-trimethylated K27 histone H3 antibodies and with anti-V5 
antibodies. The correlation blots are shown. (g) Regulation of protein levels in neuronal precursor cells by 
HMGB4 shRNA. Human neuronal precursor NTERA-2 cl. D1 cells stably overexpressing HMGB4 shRNA or 
control nonspecific shRNA were analyzed in cell ELISA. Absorbance values of HMGB4 shRNA expressing cells 
were normalized to values of control shRNA expressing cells (n ≥ 3, ± SD, *p < 0.03). H2A K5 Ac = histone 
H2A acetylated lysine 5, H4 K8 Ac = histone H4 acetylated lysine 8.
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Since PPP1R14a is a marker of mature oligodendrocytes both in mammals and in zebrafish28,29 we hypothe-
sized that HMGB4 may have functions in differentiation of brain cells. This hypothesis is further supported by 
the fact that HMGB4 is expressed in the brain (Supplementary Figure S2) where its expression is associated to 
extracellular region processes (Table 1). In addition, polymorphisms in the HMGB4 gene locus have been associ-
ated with psychiatric diseases13–16. We found mRNA coding for HMGB4 and HMGB4L1 in cultured rat neurons 
(Fig. 1f). Immunofluorescence staining of rat brain cell cultures with an anti-HMGB4L1 antibody indicated that 
HMGB4L1 is co-expressed with nestin and neuronal nuclei antigen (NeuN) in neurospheres and in vitro differ-
entiated neuronal cells, respectively (Fig. 6a,b). In neurosphere cultures HMGB4L1 co-localizes with histones in 
the cell nucleus (Fig. 6c,d). Although the expression of HMGB4 decreases during neurosphere differentiation into 
neurons5, our results indicate that differentiated neurons still express some HMGB4/HMGB4L1.
Downregulation of HMGB4 in mouse embryonic neurons by specific Vivo-Morpholinos upregulated the 
expression of PPP1R14a mRNA by 2.75 fold when compared to the expression in neurons treated with standard 
control Vivo-Morpholinos (Fig. 5b). This result and the fact that HMGB4 is downregulated during neurosphere 
differentiation5 suggests that HMGB4 might regulate the development of neuronal tissue. Hence, the effect of 
endogenous HMGB4 on differentiation of neuronal precursor cells was studied with the well-characterized neu-
ronal precursor cell line model NTERA-2 cl. D1 that expresses HMGB4 (Fig. 3g and ref. 30). To monitor the 
effect of HMGB4 loss on the regulation of neuronal differentiation-related gene expression we stably transfected 
NTERA-2 cl. D1 cells with HMGB4 shRNA to down-regulate the expression of HMGB4, and we conducted a 
qPCR-array. The array revealed a large number of genes to be affected (Table 2). Downregulation of HMGB4 in 
NTERA-2 cl. D1 cells, for instance, upregulated the gene expression of the neuroblast formation marker, ASCL1, 
and downregulated the mature neuron and astrocyte gene expression markers, FABP7, CNP, MBP, NR4A2 and 
NEUROD1. Further, downregulation of HMGB4 decreased the expression of the neuronal cell adhesion and mat-
uration molecule, NCAM1 -coding gene (Table 2). Taken together, these results indicate that HMGB4 regulates 
the expression of genes involved in maturation and differentiation of neuronal precursor cells.
Discussion
In this study, we show that HMGB4 and the highly similar HMGB4L1, regulate chromatin and differ in many 
aspects from HMGB1, the archetype member in the family of HMGB proteins. Furthermore, according to our 
knowledge, this is the first study elucidating the functions of endogenous HMGB4 in somatic cells showing reg-
ulation of gene expression by HMGB4.
Human and mouse genomes have a single HMGB4 gene whereas in rat, in addition to the HMGB4 gene 
on chromosome 5, a similar HMGB4L1 gene exists on chromosome X. Rat, mouse and human HMGB4 genes 
have a similar genomic organization within an intron of the CSMD2 gene31, which clearly differs from the 
genomic organization of the HMGB4L1 gene that is localized to rat X -chromosome. The transcripts HMGB4 
and HMGB4L1 are, however, similar suggesting that the HMGB4L1 gene originates from the HMGB4 gene. 
Furthermore, similar expression patterns in rat cells and tissues and similar behavior in cells, suggest a close 
relationship between the two proteins.
Among species, HMGB1, -2 and -3 intron - exon structures and coding sequences are highly conserved32. In 
this respect the HMGB4 and HMGB4L1 genes seem to differ from other HMGB genes. The coding sequences are 
less conserved between rat HMGB4 and HMGB4L1. Further, the HMGB4 gene is less conserved across different 
Term Count % p-value FDR
293T cells HMGB4-EGFP overexpression
GO:0007155 ~ cell adhesion 44 7.82 0.000002 0.003
GO:0022610 ~ biological adhesion 44 7.82 0.000002 0.003
PIRSF002048:histone H2A 7 1.24 0.000003 0.004
GO:0001568 ~ blood vessel 
development 22 3.91 0.000007 0.013
IPR002119:Histone H2A 7 1.24 0.000009 0.014
GO:0000786 ~ nucleosome 11 1.95 0.000012 0.016
GO:0001944 ~ vasculature 
development 22 3.91 0.000011 0.019
SM00414:H2A 7 1.24 0.000022 0.027
citrullination 7 1.24 0.000021 0.030
IPR007125:Histone core 9 1.60 0.000030 0.046
repeat:TNFR-Cys 3 7 1.24 0.000029 0.048
Human brain endogenous HMGB4
GO:0005576 ~ extracellular region 73 16.01 0.000030 0.040
Table 1.  Biological processes associated with HMGB4 expression. HMGB4-EGFP and EGFP -expressing 
HEK 293T -cell clones were subjected to microarray gene expression analysis. Expression data of human brain 
tissue samples was obtained from Medisapiens Ltd. Expression data was analyzed with the PANTHER software 
to detect changes in the gene expression related to various biological processes. Percent of gene hits against total 
were calculated. Clusters and subclusters with highest values are shown in detail.
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Figure 4. HEK 293T -cells overexpressing HMGB4-EGFP have increased sensitivity to topoisomerase 
inhibitors and altered histone variant composition. (a) Growth of HEK 293T -cell clones with doxycycline 
induced HMGB4-EGFP or EGFP -expression. The expression of HMGB4-EGFP or EGFP in cells was induced 
over one week with doxycycline and viability was measured with CellTiterGlo Luminescent assay reagent via 
ATP quantification. (b) Growth of stable HEK 293T -cell clones, constantly expressing HMGB4-EGFP or EGFP. 
Cells were cultured for 72 h and viability was measured as described above. (c) Overexpression of HMGB4 
increases cell sensitivity to topoisomerase inhibitors. Cells overexpressing HMGB4-EGFP were more sensitive 
to topoisomerease inhibitors than control cells expressing EGFP. Figure shows representative curves from 
two different experiments. (d) Quantification of histone H3 variants of HMGB4-EGFP or EGFP-expressing 
HEK 293T -cell clones. Histones were isolated from the cells and analyzed with RP-HPLC. Histone peaks were 
identified according to their relative retention times. Histone H3.1 eluted in two peaks (H3.1 I and H3.1 II). 
Curves are derived from three EGFP -control cell clone analyses and from three HMGB4-EGFP –cell clone 
analyses. (e) Maximal core histone peak heights of RP-HPLC (see above) were determined with the UNICORN- 
software. Peak height sum of core histones was determined as 100% and relative peak heights were calculated. 
The relative amount of histone H3.2 was elevated in the HMGB4-EGFP -expressing cells when compared to the 
control cells (n = 3, ± SD, *p < 0.05).
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Figure 5. Expression of PPP1R14a is regulated by HMGB4. (a) Inhibition of PPP1R14a expression in HEK 
293T -cells constitutively expressing HMGB4-EGFP. Three independent repeats were analyzed by comparing 
representative EGFP expressing control and HMGB4-EGFP expressing cells. Results from representative 
analysis are shown. (b) Mouse E14 cortical neurons and C2C12 myoblast cells, both expressing endogenous 
HMGB4 mRNA, were treated with HMGB4 Vivo-Morpholino to downregulate translation of HMGB4. The 
expression levels of PPP1R14a were analyzed with qPCR. The levels of the PPP1R14a transcript in HMGB4 
Vivo-Morpholino -treated cells were normalized to the PPP1R14a transcript levels in control Vivo-Morpholino 
-treated cells (*p < 0.05, ± SEM; n = 6 in C2C12 experiment; n = 18 in neuron experiment).
www.nature.com/scientificreports/
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species than the HMGB1, -2 or -3 genes. Whereas human HMGB1, -2 or -3 have hardly any amino acid changing 
mutations, human HMGB4 has a non-synonymous SNP (Fig. 2b).
Our results suggest that HMGB4 and HMGB4L1 may influence chromatin structure. HMGB4 increased the 
relative expression of the histone H3.2 that has been shown to contain silencing modifications and to associate 
with facultative heterochromatin33,34. In addition, HMGB4 associated with HDACs, reduced the acetylation level 
of the lysine residues of histones H2A, H3 and H4 and increased the level of trimethylation of lysine 27 of histone 
H3. Also HMGB4L1 was found to reduce the acetylation level of the lysine residues of histone H3 and increase 
level of trimethylation of lysine 27 of histone H3.These findings suggest a role for post-translational modifications 
of histones in the regulation of transcription by HMGB4. In addition, overexpression of HMGB4 made cells more 
susceptible to death by topoisomerase inhibitors suggesting that topoisomerase-related mechanisms are mediat-
ing the survival of HMGB4 -expressing cells.
The acidic tail that mediates the binding of HMGB1 to histone H1 is lacking in HMGB4 and may explain the 
poor binding of HMGB4 to histone H135. In FRAP-analyses, HMGB4, HMGB4L1 and an acidic tail- deleted form 
of HMGB1, resembling the domain structure of HMGB4 and HMGB4L1, show lower mobility in the nucleus 
compared to the full-length form of HMGB119,20. Furthermore, truncated HMGB2 lacking an acidic tail binds 
to chromosomes more strongly than the full-length form of HMGB236. Thus, the acidic tail seems to weaken the 
association of HMGB -proteins to nuclear structures.
Microarray analyses of HMGB1 -deleted cells and tissues have revealed some changes in gene expression37,38. 
In this study, significant changes in gene expression were seen in neuronal precursor cells in which HMGB4 was 
knocked down. In addition, the ectopic overexpression of HMGB4 in transformed cells caused drastic changes in 
the expression of hundreds of genes, indicating the potency of HMGB4 to regulate transcription. The pronounced 
effects of HMGB4 on transcription are consistent with its strong binding to the nucleus, interactions with histones 
and regulation of histone variant expression.
Most somatic cell types do not express HMGB4 or express it at only very low levels. Exceptions are neuros-
pheres and neurons and we hypothesized that HMGB4 might regulate transcription in neuronal cells. Our results 
show that inhibition of endogenous HMGB4 in cells downregulated markers of mature neurons. The oligoden-
drocyte maturation marker PPP1R14a was strongly downregulated by HMGB4 and upregulated in cells with 
downregulated endogenous HMGB4 expression28,29. PPP1R14a gene expression is regulated by various factors 
including NeuroG2, Hoxb1b (a zebrafish Hoxa1 homolog) and SP1/339–41. The zebrafish PPP1R14a homolog 
PPP1R14al regulates both early and late brain development in the embryonal stage suggesting that HMGB4 may 
regulate brain development via a PPP1R14a mediated mechanism in mammals40.
Inhibition of endogenous HMGB4 expression in neural progenitor cells caused most prominently the 
downregulation of the Neuro D1 gene (Table 2), a potent neural differentiation factor42. The downregulation 
of this transcription factor would be consistent with the view that HMGB4 regulates neural differentiation by 
GENE CELL TYPE/FUNCTION AVERAGE (±SE MEAN) P
DOWNREGULATED
NEUROD1 TRANSCRIPTION FACTOR ENHANCING NEURONAL DIFFERENTIATION 0.071 ± 0.017 0.014
MBP OLIGODENDROCYTE 0.114 ± 0.026 0.000001
FABP7 ASSOCIATED TO RADIAL GLIA AND NEUROGENESIS 0.123 ± 0.025 0.000001
SLC32A1 GABA NEURON 0.132 ± 0.042 0.01
HMGB4 NEURON 0.237 ± 0.052 0.0001
NR4A2 DOPAMINERGIC NEURON 0.301 ± 0.073 0.003
NCAM1 MATURE NEURON 0.357 ± 0.084 0.035
GFAP ASTROCYTE 0.377 ± 0.087 0.012
CNP OLIGODENDROCYTE 0.606 ± 0.011 0.011
UNREGULATED
MAPT NEURON 0.327 ± 0.071 0.15
S100B MATURE NEURON, ASTROCYTE 0.438 ± 0.12 0.13
PAX6 RETINAL PROGENITOR 0.449 ± 0.094 0.19
GAD2 GABA NEURON 0.478 ± 0.15 0.15
FOXG1 MOTONEURON 0.626 ± 0.19 0.21
OLIG2 OLIGODENDROCYTE PROGENITOR 1.035 ± 0.22 0.92
NKX2-2 OLIGODENDROCYTE PROGENITOR, OLIGODENDROCYTE 1.052 ± 0.17 0.85
SLC1A2 GLUTAMATERGIC NEURON 1.118 ± 0.31 0.80
SLC1A3 GLUTAMATERGIC NEURON 1.217 ± 0.24 0.55
EMX1 NEURON 1.644 ± 0.44 0.26
UPREGULATED ASCL1 NEUROBLAST FORMATION 3.917 ± 1.40 0.01
Table 2.  Neuronal differentiation qPCR-array of HMGB4 shRNA -infected NTERA-2 cl. D1 cells.  Gene 
expression was analyzed with neuronal differentiation qPCR array and with HMGB4 qPCR, and the expression 
levels of HMGB4 shRNA -infected cells were normalized to the expression levels of control shRNA -infected 
cells. Average fold changes in gene expression are shown (n = 4 in neuronal differentiation qPCR array, and in 
HMGB4 analysis n = 3 for controls and n = 12 for HMGB4). One-way ANOVA was used to calculate p-values.
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modulating gene expression in neural cells. The finding that expression of several neuronal and glial genes is 
downregulated together with Neuro D1 (Table 1) is also consistent with this view.
In contrast, the ASCL1 gene was found to be upregulated upon inhibition of endogenous HMGB4 (Table 2). 
ASCL1 is a transcription factor essential for the formation of neuroblasts, proliferating precursors of neurons43. It 
appears that downregulation of HMGB4 expression in neuronal precursors allows cells to advance to the neuro-
blast stage. Expression of HMGB4 in mature neurons may be then required to maintain and modify the neuronal 
phenotypes during adult neuronal plasticity.
In conclusion, HMGB4 differs from other mammalian members of the HMGB-family. It binds strongly to 
nuclear structures, regulates chromatin and mediates differentiation of neuronal cells. Strong effects on tran-
scription, and regulation of different histone forms likely underlie the prominent effects of HMGB4 on cell 
differentiation.
Materials and Methods
Sequence analyses. Homology searches of nucleotide databases and SNP-analyses were done using tools 
on the websites of the Center for Biotechnology Information (Rockville Pike, Bethesda, Maryland, USA) and 
Ensembl (EMBL-EBI and the Sanger Institute, Cambridgeshire, United Kingdom). Sequence alignments were 
done using ClustalW on the EMBnet website (The ISREC Bioinformatics Groups, Epalinges, Switzerland). 
Protein domains were detected using the Pfam program (Wellcome Trust Sanger Institute, Cambridge, UK.). 
The human HMGB4 isoform was detected in genomic DNA isolated from cultured cells and amplified with 
primers atgggaaaagaaatccagcta and ggatccatcagctctgcctg. The amplified DNA was analyzed with Ban 1 restriction 
digestion to detect rs10379 SNP that lacks the Ban 1 cleavage site. Gene expression data of human brain areas was 
obtained from Medisapiens Ltd. (Medisapiens Ltd, Helsinki, Finland). Gene clusters associating with HMGB4 
were analyzed with PANTHER –software44.
Recombinant protein Western blot. Recombinant mouse HMGB4 was produced in HMGB4 cDNA 
-containing pGEX-6P-1 plasmid-transformed bacteria using previously described methods45. Recombinant 
HMGB1 was produced as described46. Recombinant proteins were analyzed in anti-HMGB4 (Abcam, Cambridge, 
UK) and anti-HMGB4L1 (anti-TP4)7 Western blot.
Northern blot. Total RNA was isolated from laboratory mouse and rat organs, and electrophoresed using 
agarose gels. Probes were produced from the entire coding sequence of mouse HMGB4 or rat HMGB4L1 cDNAs 
by PCR. RNA was blotted onto nylon filters, blocked, and probed with 32P-labelled probes using conventional 
Northern-blotting methods.
Immunohistochemistry. 4% PFA-fixed, paraffin embedded tissue sections of adult rat testis were depa-
raffinized in a decreasing series of alcohol. The antigen was unmasked by heating the sections in 10 mM Na-citrate 
buffer for 15 min in a microwave oven. The sections were then rinsed in PBS and endogenous peroxidase was 
blocked by incubating the sections in 3% H2O2 in PBS. Unspecific binding sites were blocked by incubation in 5% 
fat-free milk powder in PBS for 1 h at room temperature. The anti-HMGB4L1 antibody was then applied in a 1:50 
dilution in blocking solution and the sections were incubated at 4 °C overnight. The primary antibody was washed 
off with PBS and the sections were incubated for 1 h at room temperature in a 1:300 dilution of anti-rabbit-HRP 
antibody (GE Healthcare, Pittsburgh, PA, USA) in blocking solution. The antigen was detected by incubating 
the sections in aminoethylcarbazole substrate (Sigma-Aldrich, St. Louis, MO, USA). Nuclei were visualized by 
counterstaining in haematoxylin.
In Situ Hybridization. Sequences for antisense and sense probes were obtained from Allen Brain Atlas 
(Allen Institute for Brain Science, Seattle, WA, USA) and digoxigenin-labelled RNA probes were produced. 
Paraffin-embedded sections of adult mouse testis were deparaffinized, washed and digested and permeabilized 
with proteinase K and Triton X-100. Sections were washed and refixed in 4% PFA. After washing, sections were 
hybridized with either antisense or sense probes at 65 °C overnight, washed and blocked with 2% sheep serum, 
2mg/ml BSA in PBS/Triton X-100. The sections were then incubated in anti-digoxigenin-AP antibody (Roche, 
Mannheim, Germany) 1:2000 in blocking solution at 4 °C overnight, washed and detected in alkaline phosphatase 
buffer with nitro-blue tetrazolium and 5-bromo-4-chloro-3′ -indolyphosphate (Sigma-Aldrich) as substrates in 
the dark.
Cells and tissues. Rat hippocampal neurons were isolated and cultured as described47. Rat cerebellar neu-
rons were isolated from young rats, and cultured in DMEM supplemented with 10% FCS, 2 mM glutamine, 
25 mM KCl, penicillin and streptomycin. Rat neurospheres were isolated as described and cultivated in NeuroCult 
NSC Basal Medium containing Proliferation Supplements (StemCell Technologies, Vancouver, Canada)48. Mouse 
neurons were isolated from E14 mouse cerebral hemispheres as described48.
RT-PCR analysis of gene expression. Total RNA was isolated from rat neurons using RNeasy kit (Qiagen, 
Valencia, CA, USA) and treated with DNAse I (Roche), and reverse transcribed using M-MLV reverse tran-
scriptase (Promega, Madison, VI, USA). DNA was amplified using DynaZyme DNA-polymerase (Finnzymes, 
Espoo, Finland) using oligos atgggaaaagacagcaaagtaagacc and ttactccccgcgctggcatt for rat HMGB4L1, or atggg-
gaaaaaagtccagctaagac and ttattctttcaaactgcttttggacg for rat HMGB4. Resulting products were analysed in agarose 
gel electrophoresis.
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Figure 6. Expression of HMGB4 and HMGB4L1 in cultured primary cells of rat brain. (a) 
Immunofluorescence staining of nestin and HMGB4L1 in 1d differentiated rat neuronal cells in vitro. 
Neurospheres were allowed to adhere and differentiate for 1 day and cells were immunofluorescently 
stained with anti-nestin and anti-HMGB4L1 antibodies. Cell nuclei were stained with DAPI. The staining 
controls for anti-nestin or anti-HMGB4L1 staining were done without primary antibody or with preimmune 
serum, respectively. Scale bar = 30 μ m. (b) Immunofluorescence staining of HMGB4L1 and NeuN in 14d 
differentiated rat neuronal cells in vitro. Neurospheres were allowed to differentiate for 14 days and cells were 
immunofluorescently stained with anti-NeuN and anti-HMGB4L1 antibodies. Staining controls for anti-
HMGB4L1 and anti-NeuN were done with pre-immune serum or without primary antibody, respectively. 
Scale bar = 20 μ m. (c,d) Proximity ligation assay of neurospheres with anti-PAN-Histone and anti-HMGB4L1 
antibodies. Cell nuclei of cultured neurospheres were stained with DAPI and a proximity ligation assay was 
performed with anti-PAN-Histone antibodies and preimmune control serum (c) or with anti-PAN-Histone 
antibodies and anti-HMGB4L1 antibodies (d). Scale bar = 20 μ m.
www.nature.com/scientificreports/
13Scientific RepoRts | 6:32960 | DOI: 10.1038/srep32960
Immunofluorescence of modified histone H3 proteins. Rat HMGB4 and HMGB4L1 cDNAs were 
cloned into pcDNA6 plasmids (Life Technologies, Carlsbad, CA, USA). C6 -cells were transfected with the 
plasmids and cultured overnight to allow for the expression of V5-tagged proteins. The cells were immunoflu-
orescently stained with anti-V5-tag (Thermo Fisher Scientific Inc., Rockford, IL, USA) and with anti-modified 
histone H3 antibodies (anti-histone H3 acetylated K9/K14, anti-histone H3 di-methylated K27 and anti-histone 
H3 tri-methylated K27; Millipore, Billerica, MA, USA) to identify HMGB4- and HMGB4L1- expressing cells and 
to detect modified histones. Digital pictures were taken and analyzed with ImageJ software49.
Cloning of EGFP-fusion proteins. cDNA coding for mouse HMGB4 was cloned to a pEGFP-N1 vector 
(ClontechTakara Bio Company, Shiga, Japan). Mouse HMGB1-EGFP and an empty EGFP-vector served as con-
trols. Rat HMGB4L1, human HMGB4 and human HMGB4 rs10379 SNP -variant were cloned to a pEGFP-C1 
vector (ClontechTakara Bio Company). HMGB4-EGFP- and EGFP- coding lentiviruses were produced 
using a method described earlier50 and they were used to produce stable doxycycline-inducible or constantly 
HMGB4-EGFP or EGFP –overexpressing HEK 293T -cells.
FRAP analyses. NIH-3T3 cells were transiently transfected with EGFP-tagged proteins. Confocal imaging 
was performed using a Leica SP2 AOBS confocal microscope (Leica Microsystems GmbH, Wetzlar, Germany) at 
the Light Microscopy Unit of the Institute of Biotechnology, University of Helsinki. For comparing the mobility 
of HMGB1 (n = 6), HMGB4 (n = 4) and HMGB4L1 (n = 5) three pre-bleach images were taken followed by 
two bleach pulses at 488 nm covering half of the nucleus. Images were collected at different time points after 
bleaching. To compare the effects of SNP on the mobility of HMGB4, five pre-bleach images were taken followed 
by three bleach pulses at 488 nm, quenching one brightly fluorescent area/nucleus. Post-bleach -images were 
collected at different time points.
The fluorescence images were analyzed using Leica Confocal software (Leica Microsystems GmbH). Recovery 
curves were generated without subtracting the background, and t1/2 was calculated as described51.
Affinity chromatography analyses. Recombinant HMGB1 and HMGB4 were coupled to Sepharose-affinity 
column and affinity chromatography of C6 –cell nuclear proteins was done as described22. Histone contents in 
flow through and eluted protein fractions were analyzed with SDS-PAGE and histone-ELISA using previously 
described methods22. HDAC -activity in the starting material, in flow through and in eluted protein fractions was 
analyzed with substrate Ac-Arg-Gly-Lys(Ac)-AMC (Anaspec, Fremont, CA, USA) as described52. Sirtuin -activity 
was measured using the same assay with additional 1 mM nicotinamide adenine dinucleotide (Sigma-Aldrich) 
and 600 nM trichostatin A (Sigma-Aldrich) in the assay buffer. The protein content in the samples was analyzed 
with the BioRad protein assay (Biorad, Hercules, CA, USA).
Gene and protein expression analyses of NTERA-2 cl.D1 cells. NTERA-2 cl. D1 cell were obtained 
from the American Type Culture Collection (Manassas, VA, USA). Human HMGB4 shRNA was purchased from 
Fisher Scientific (Pittsburgh, PA, USA). The control shRNA was produced as described50. Cells were infected with 
lenti-viruses and positive cells were selected after puromycin treatment50. RNA was isolated from the cells, reverse 
transcribed and analyzed with qBiomarker Validation PCR Array Neuronal Differentiation (Qiagen). The expres-
sion level of HMGB4 was analyzed in separate qPCR with specific primers. Protein levels in cells were measured 
with cell ELISA as described previously53. The following antibodies were used in cell ELISA: mouse anti-β -Actin 
(clone AC-15; Sigma-Aldrich), mouse anti-GFAP (clone G-A-5; Sigma-Aldrich), mouse anti-NCAM (clone 5B8; 
Developmental Studies Hybridoma Bank, University of Iowa, Iowa City, IA, USA), rabbit anti-ASCL1 (Biobryt 
Ltd., Cambridgeshire, UK), rabbit anti-human HMGB4 (Boster, Pleasanton, CA, USA), rabbit anti-histone H2A 
acetylated Lys5 and rabbit anti-histone H4 acetylated Lys8 (Cell Signaling Technology, Danvers, MA, USA).
Stable cells expressing HMGB4-EGFP and EGFP. HEK 293T -cells were infected with lenti-viruses 
coding for HMGB-EGFP or EGFP fusion proteins and stably over-expressing clones were obtained from single 
cells.
Drug sensitivity and resistance testing screen. Stable HEK 293T –cells constantly over-expressing 
HMGB-EGFP or control EGFP were seeded in a density of 1000 cells per well in 384 -well plates. 279 compounds 
from the FIMM (Institute for Molecular Medicine Finland, Helsinki, Finland) oncology collection library were 
added in different concentrations. After 72 h of incubation (at 37 °C; 5% CO2), cell viability was measured by 
CellTiterGlo Luminescent assay (Promega). The screen was described in details earlier23.
Microarray analyses of HMGB4-EGFP over-expressing HEK 293T -cell clones. Human embryonic 
kidney HEK 293T -cells stably over-expressing HMGB-EGFP or control EGFP were cultured to the sub- conflu-
ent stage and RNA was isolated with Trizol (Thermo Fisher Scientific Inc.). aRNA was amplified with Amino Allyl 
MessageAmp II aRNA Amplification Kit (Thermo Fisher Life Technologies, Waltham, MA, USA) and labeled 
with CyDye Post-Labelling Reactive Dye (GE Healthcare).
Unrestricted Human Genome Microarray 4x44K microarray slides (Agilent, Santa Clara, CA, USA) hybrid-
ized with HEK 293T –cell-derived labelled aRNA were scanned by an Axon GenePix 4200 AL (Molecular 
Devices, Downington, PA, USA) scanner and median intensity of each spot was estimated using GenePix Pro 6.0 
software (Molecular Devices, Sunnyvale, CA, USA). The data were analyzed with R and Bioconductor package 
Limma54. The linear model and empirical Bayesian methods were applied to find differentially expressed genes 
(p-value < 0.01). Function annotation clustering of differentially expressed genes was analyzed in DAVID55.
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RP-HPLC analyses of histone variants. Histones from stable HEK 293T -cell clones overexpressing 
HMGB4-EGFP or EGFP were acid-extracted as described56. Histone RP-HPLC with acetonitrile buffers as a 
mobile phase was done as described using ÄKTA Micro RP-HPLC equipped with a Resource 5 RPC column (GE 
Healthcare)56.
Vivo-Morpholino -induced translational inhibition. Mouse PPP1R14a expression levels in E14 
mouse cortical neurons treated with Vivo-Morpholinos (Gene Tools LLC, Philomath, OR, USA) for 6 days 
and C2C12 -cells treated with Vivo-Morpholinos for 3 days were analyzed with qPCR. Morpholino sequences 
were 5′ tggtctttttcccccatgtttatac-3′ (mouse HMGB4 start) and 5′ -cctcttacctcagttacaatttata-3′ (standard control). 
Morpholinos were added to cells in a 1/800 dilution.
Analysis of merlin. Phosphorylated merlin Western –blots were done as described previously24.
Immunofluorescence staining of neurospheres and neurons. Rat neurospheres were isolated as 
described and cells were allowed to adhere and differentiate for 1 to 14 d48. Subsequently, cells were immuno-
fluorescently stained with anti-nestin (Developmental Studies Hybridoma Bank), anti-HMGB4L1 or anti-NeuN 
(Millipore) antibodies. Cell nuclei were stained with 4′ ,6-diamidino-2-phenylindole (DAPI; Sigma-Aldrich). 
Controls for nestin or HMGB4L1 stainings were performed without the primary antibody or with preimmune 
serum. A proximity ligation assay of neurospheres with anti-PAN-Histone (Millipore), anti-HMGB4L1 antibod-
ies and preimmune control serum was done using Duolink Kit (Olink Bioscience, Uppsala, Sweden).
Ethics statement. The animal experiment permits were obtained from the Office of the Regional 
Government of Southern Finland (license number ESAVI/6603/04.10.03/2011) in agreement with the ethical 
guidelines of the European convention. All experimental protocols were carried out in accordance with the 
approved guidelines of the Laboratory Animal Centre (LAC) of the University of Helsinki.
Statistical analysis. qPCR data was examined as described57. Other values were calculated with Excel 
(Microsoft Corporation, Redmond, WA) and are expressed as means ± SD. The data were examined using 
Student’s t-test or Pearson correlation analyses to calculate p-values. For all statistical tests, significance was 
accepted at p < 0.05.
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